麻豆视频

North America Spirulina Extract Market Trends and Insights

Growing Use of Spirulina in Dietary Supplements and Functional Foods

Spirulina鈥檚 high protein content (55鈥�70% dry weight) makes it an efficient, sustainable source of amino acids, supporting the growing US organic supplement market, which reached USD 5.9 billion in 2023^{[1]Source: U.S. Department of Agriculture, 鈥淥rganic Supplement Sales Data,鈥� usda.gov}. A 2025 meta-analysis confirmed the benefits for body composition, providing formulators with clinical evidence for labeling and marketing. E.I.D. Parry鈥檚 USP Dietary Ingredient Verification highlights the rising importance of third-party quality assurance, while Lonza鈥檚 2025 Organicaps pullulan capsules enable fully organic spirulina supplements without gelatin, opening premium retail shelf space. The market is also shifting toward multi-ingredient blends that include ashwagandha, turmeric, or omega-3 fatty acids, thereby expanding overall volume despite the fragmentation of SKUs.

Expansion of Clean-Label and Organic Product Formulations

Clean-label trends are driving the growth of spirulina, whose single-ingredient profile provides transparency that synthetic colorants cannot. The FDA鈥檚 2025 updates to the 鈥渉ealthy鈥� claim and GNT USA鈥檚 2022 approval for dairy alternatives and plant-based beverages position spirulina for front-of-pack nutrition messaging and 15鈥�20% price premiums. Canada鈥檚 SFC traceability rules favor local producers with farm-to-facility documentation, limiting offshore imports. While organic certification adds USD 0.50鈥�1.00/kg in costs, certified organic spirulina commands wholesale prices 40鈥�60% higher, making it attractive for mid-sized premium brands.

Rising Demand for Plant-Based and Natural Nutritional Ingredients

Plant-based diets are driving demand for spirulina, valued for its complete amino acid profile and allergen-free properties. SimpliiGood鈥檚 2025 launch of spirulina-based smoked salmon shows its potential in whole-food analogs, while its natural blue-green color is now a selling point in vibrant smoothies and functional beverages. In Mexico, the wellness food market grew 14.7% CAGR to USD 33.8 billion (2019鈥�2023), with fortified foods gaining traction. Rising incomes and the Canada-Mexico Organic Equivalency Arrangement enable Canadian producers to expand spirulina-fortified products into Mexico without duplicative certification.

Increasing Consumer Focus on Preventive Healthcare and Immunity Support

Spirulina鈥檚 immunomodulatory benefits, driven by phycocyanin and polysaccharides, are becoming a key commercial selling point as consumers prioritize clinically supported immune ingredients. Its antioxidant activity, at phycocyanin levels of 10鈥�15 g per 100 g biomass, supports claims of reducing oxidative stress, aligning with post-pandemic wellness trends. Spirulina鈥檚 Class A safety rating allows formulators to recommend higher daily doses (3鈥�5 g) with regulatory confidence, setting it apart from newer botanicals that lack long-term safety data^{[2]Source: United States Pharmacopeia, 鈥淰erification Program Participants,鈥� usp.org}. Canada鈥檚 2024 update to the Natural Health Product framework has shortened licensing timelines, enabling faster launches of immunity-focused blends during peak seasonal demand. However, substantiating structure-function claims remains a challenge, as the FDA requires NDI filings for novel extracts with concentrated phycocyanin, which can delay responses to trending formulations.

High Production Cost and Input-Price Volatility

Spirulina cultivation is energy- and cost-intensive, with fluctuations in electricity prices directly affecting margins. Open-pond systems in California benefit from sunlight but face rising water costs, while Hawaii鈥檚 Cyanotech facility contends with peak electricity rates exceeding USD 0.30/kWh. Nutrient inputs, such as sodium bicarbonate and nitrogen, are subject to commodity cycles; a 20% increase in bicarbonate can reduce gross margins by 3鈥�5 points^{[3]Source: Cyanotech Corporation, 鈥淚nvestor Presentation Q3 FY2025,鈥� cyanotech.com}. Closed photobioreactors offer contamination control and year-round output but require USD 2鈥�5 million per hectare, limiting access for smaller producers and concentrating production among integrated firms. Labor for harvesting, drying, and quality control accounts for 15鈥�25% of costs, with wage inflation prompting producers to consider automation or margin erosion. The market is bifurcated between commodity powder (USD 8鈥�12/kg) and pharmaceutical-grade extracts (USD 40鈥�60/kg), forcing producers to focus on either volume or premium supply chains, which limits flexibility and exacerbates fluctuations in electricity prices.

Complex FDA/CFIA Compliance for Novel Ingredients

The FDA鈥檚 NDI pathway requires manufacturers of novel spirulina products, such as fermented spirulina, concentrated phycocyanin, or hydrolysates, to submit safety dossiers 75 days prior to launch, at a cost of USD 50,000-150,000 per ingredient. In Canada, CFIA licensing now includes GMP audits and site inspections, adding 6-12 months to development and requiring dedicated regulatory staff. Mexico鈥檚 COFEPRIS permits must be filed through a local entity, which can delay foreign launches by 12鈥�18 months. Established spirulina powders benefit from GRAS status, while innovative extracts face stricter scrutiny, which slows market entry and favors incumbents.

*Our forecasts treat driver/restraint impacts as directional, not additive. The impact forecasts reflect baseline growth, mix effects, and variable interactions.

Segment Analysis

By Form: Powder Dominates, Liquid Extracts Gain in Beverages

Sensient鈥檚 March 2024 launch of a heat-stable spirulina ingredient is opening up high-temperature applications that were previously unavailable, including baked snacks and UHT beverages. In 2025, powder dominated the market with a 70.92% share, primarily due to its compatibility with tablets, capsules, and protein blends. In contrast, liquid extracts are projected to grow at a 10.65% CAGR through 2031, offering water-dispersible solutions that eliminate the gritty mouthfeel associated with powders. Tablets remain popular for dosing convenience, but demand is shifting toward capsules, especially pullulan-based organic options like Lonza鈥檚 2025 Organicaps, that avoid gelatin and synthetic polymers. Fresh, texturized spirulina, exemplified by SimpliiGood鈥檚 2025 smoked salmon analog, preserves heat-sensitive nutrients and delivers whole-food texture, appealing to flexitarian consumers.

Other innovative forms, including gummies, chews, and 鈥渃andyceuticals,鈥� are capturing younger consumers who prefer fun, convenient formats, though these require premium extracts with minimal off-flavors. Liquid spirulina products, such as YANGGE BIOTECH鈥檚 blue honey-like extract, target beverage manufacturers seeking natural blue colorants that comply with FDA 21 CFR 73.530 standards. While powder maintains volume leadership at USD 8鈥�12/kg wholesale, liquid and fresh formats are carving out premium niches, commanding 2鈥�3脳 price premiums due to superior sensory performance and clean-label appeal.

By Application: Pharma/Supplements Lead, Food/Beverage Accelerates

Pharmaceuticals and dietary supplements accounted for 45.88% of spirulina extract applications in 2025, driven by its USP Class A safety rating, clinical evidence supporting improvements in body composition, and compatibility with multi-nutrient blends targeting immunity, energy, and cognitive health. Food and beverage applications, although smaller in volume, are growing at a 9.89% CAGR through 2031, supported by the FDA鈥檚 2022 approval, which expands the use of spirulina as a natural colorant in confections, ice cream, yogurt, cereals, and ready-to-drink beverages. This enables formulators to replace synthetic Blue 1 while adding protein and micronutrients. Animal feed applications, particularly in aquaculture and poultry, benefit from research showing improvements in growth performance and partial to full replacement of soybean meal, although adoption is largely limited to premium operations due to cost sensitivity.

Industrial applications, including cosmetics, biofuels, and biostimulants, remain niche but are attracting R&D investment as producers seek to monetize byproducts and improve biorefinery economics. For example, DIC Corporation鈥檚 investment in Back of the Yards Algae Sciences鈥� zero-waste platform demonstrates how extracting colorants, biostimulants, and heme analogs from the same biomass can diversify revenue streams. Overall, while supplements provide stable demand, the fastest growth is in food and beverage, where spirulina鈥檚 dual functionality, nutrition plus natural color, supports clean-label positioning. Regulatory clarity, such as FDA approval for specific coloring uses, is critical for market expansion, whereas animal feed growth remains constrained by inconsistent offshore quality and the lack of standardized dosing guidelines.

Geography Analysis

The United States dominated North America鈥檚 spirulina ingredient market in 2025, accounting for 78.02% of regional revenue. Key production hubs include California鈥檚 Earthrise facility (108 acres in Calipatria) and Hawaii鈥檚 Cyanotech operation (96 acres in Kona), both of which benefit from year-round sunlight, established supply chains, and proximity to downstream nutraceutical formulators in Southern California and the Pacific Northwest. Cyanotech reported Q3 FY2025 net sales of USD 6.172 million, up 10.6% year-over-year, reflecting strong demand from contract manufacturers for USP-verified, GMP-certified spirulina for private-label supplements and functional foods. The FDA鈥檚 2022 approval, which expands the use of spirulina as a natural colorant in confections, ice cream, yogurt, cereals, and beverages, has further opened up margin-rich food and beverage applications. High production costs in California and Hawaii, driven by electricity (USD 0.15鈥�0.30/kWh), labor, and environmental compliance, push producers to compete on quality, traceability, and regulatory alignment rather than price.

Canada鈥檚 spirulina market is shaped by CFIA regulations, which require site licensing, GMP audits, and product-specific approvals, adding 6鈥�12 months to commercialization but creating a quality moat that protects compliant producers. The Canada Organic Regime (COR) mandates certification for organic spirulina, while the February 2023 Canada-Mexico Organic Equivalency Arrangement enables Canadian producers to access Mexico鈥檚 growing middle-class market without duplicative audits. Canada鈥檚 2024 modernization of its self-care framework has accelerated Natural Health Product licensing, allowing faster launches of spirulina-based immunity blends to capitalize on seasonal demand peaks. Though smaller than US producers, Canadian companies such as C.B.N. Spirulina Canada Co. leverage regulatory alignment and proximity to US markets to serve cross-border supply chains for both organic and non-GMO formulations.

Mexico is the fastest-growing North American market, projected to expand at a 9.44% CAGR through 2031, supported by a health-and-wellness packaged food sector valued at USD 33.8 billion in 2023. Fortified and functional foods account for 30.4% of this market, creating opportunities for spirulina-fortified tortillas, protein bars, and beverages. Rising population and per capita income, alongside COFEPRIS regulations and NOM-051 labeling requirements, shape market entry, often favoring partnerships with US and Canadian producers. Currently, Mexico receives a significant portion of processed food exports from the US (65.2%), suggesting spirulina ingredients are largely imported through US-based formulators and contract manufacturers. Other North American regions, primarily Caribbean markets, remain limited in size due to low local production, high import costs, and nascent consumer awareness.

Regulatory Landscape

In the United States, spirulina extract is regulated as a color additive exempt from certification under FDA 21 CFR 73.530, with use limited to specific food categories and subject to Good Manufacturing Practice (GMP) and specifications (including limits tied to contaminants such as heavy metals). A key 2026 inflection point occurred when FDA published a February 6, 2026 final order to expand approved uses of spirulina extract as a color additive in human foods generally (with exclusions such as infant formula). FDA then announced an indefinite delay on March 20, 2026 after receiving objections and a request for a hearing, leaving the narrower, currently listed use scope in effect pending further action.

In Canada, spirulina extract is managed through Health Canada permissions for food use via the List of Permitted Colouring Agents (notably for unstandardized foods) and is also referenced for natural health products through the Natural Health Products Ingredients Database (NHPID) with established quality and labeling expectations. Across North America, companies commercializing novel spirulina-derived ingredients with higher concentrations or altered processing may still face additional compliance burdens (for example, dossiers and notifications in the United States for new dietary ingredient pathways), which can extend timelines compared with established spirulina powders.

Value Chain Analysis

The North American spirulina extract value chain begins with inputs and cultivation infrastructure, including water, nutrients such as sodium bicarbonate and nitrogen sources, energy, and controlled growing systems. Biomass is produced in open-pond raceways and, for higher-control output, in photobioreactors. Large integrated producers such as DIC Corporation's Earthrise Nutritionals (Imperial Valley, California) and Cyanotech (Hawaii) anchor domestic supply, while other participants focus on specialized extraction or formulation capabilities for phycocyanin-rich color systems and nutraceutical grades.

Midstream operations include harvesting, drying (for powder), and pigment/protein extraction, where phycocyanin is typically recovered through water-based processing and purified to meet customer specifications and regulatory limits. Downstream, B2B channels supply dietary supplement brand owners, contract manufacturers, and food and beverage formulators seeking natural blue and blue-green shades, with additional QA requirements (GMP programs and third-party certifications) shaping supplier selection. Distribution includes direct contracting for consistent lots and formulation support, as well as ingredient distributors for smaller buyers. Managing variability, including batch-to-batch color strength, taste and odor control, and contaminant specifications, remains a key gating factor for scale in high-volume food applications.

Market Opportunities and Future Outlook

A primary opportunity lies in substituting synthetic blue dyes in mainstream food and beverage, supported by the established FDA listing for spirulina extract under 21 CFR 73.530 and ongoing product innovation aimed at improving stability and application range. Sensient's March 2024 introduction of a heat-stable spirulina ingredient expands addressable processing conditions, including baking, extrusion, and pasteurization, creating whitespace in categories that historically avoided spirulina color due to thermal instability.

Supply-side investments and process modernization also expand commercial headroom in North America, especially where buyers prioritize traceability and consistent phycocyanin specifications. Earthrise Nutritionals commenced operations at a new Calipatria, California edible algae cultivation facility in March 2025 (reported at about a 1.2 billion yen investment), aligning capacity expansion with smart-farming controls and food-safety positioning for colorant-grade applications. At the same time, the March 2026 indefinite delay of FDA's February 2026 final order to broaden permitted uses keeps the US market operating under a narrower list of approved food categories for spirulina extract color. That constrains some near-term expansion, while concentrating opportunity around applications already covered by 21 CFR 73.530 and increasing the value of formulation workarounds, including heat-stable formats and optimized dosing under GMP.